Long-term survival and quality of life in patients more than 10 years after pelvic exenteration
In a specialized setting, pelvic exenteration shows promising long-term outcomes with one-third of patients surviving beyond 10 years. Quality-of-life measures demonstrate sustained improvement and are comparable to population norms in several domains, supporting its use as a curative treatment for selected patients with advanced and recurrent pelvic malignancies.
Authors
- Lynne Whitehead (ORCID: https://orcid.org/0000-0002-6559-5952)
- Cherry Koh (ORCID: https://orcid.org/0000-0003-2547-0204)
- Michael J. Solomon (ORCID: https://orcid.org/0000-0002-5602-6045)
- Daniel Steffens (ORCID: https://orcid.org/0000-0002-9715-860X)
- Peter Lee (ORCID: https://orcid.org/0000-0002-8244-1904)
- Sascha Karunaratne (ORCID: https://orcid.org/0000-0001-7518-0307)
- Kilian G. M. Brown (ORCID: https://orcid.org/0000-0003-0967-8515)
- Bora Kim (ORCID: https://orcid.org/0000-0002-7843-5106)
- Christopher M. Byrne (ORCID: https://orcid.org/0000-0001-6491-4184)
- Kirk K. S. Austin
Institutions
- The University of Sydney (AU)
- Royal Prince Alfred Hospital (AU)
Publication Details
- Journal
- British journal of surgery
- Published
- 2025-05-31
- DOI
- https://doi.org/10.1093/bjs/znaf123
- Citations
- 3
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.14